The first Virtual Panel Series discussion took place on the 22nd of October and was created as a dialogue platform where panelists spoke about the impact Covid-19 has had on cancer treatment and screening.

Dedicated to fostering unparalleled networking and facilitate the exchange of information, expertise and ideas among world leading scientific, academic and business minds, Precision Medicine Forum aims to deliver the most interesting opportunities related to the sharing of key information while providing relevant content to its public through different channels: social media groups, virtual panel sessions, live forum and website.

 

In the context of COVID-19, life as we all knew before completely changed, therefore all activities had to adapt to the new situation. The new virtual panel series started on the 22nd of October with a session dedicated to The impact of COVID-19 on cancer treatment and screening. Moderated by Sara Badreh, Senior Manager Health and Research Projects at the European Cancer Patient Coalition, the webinar tackled topics such as quantifying the impact of COVID-19 on cancer screening, tests, and treatment, but also creating a safe environment for cancer patients as we emerge from lock-down. Moreover, the panelists discussed ways to develop a strategy to increase hospital testing capacity, increase turn-around times, and prioritise effectively and lessons learned for future pandemics.

You can now watch down below the two sessions taking place of the 22nd of October: The European Session (11:00 AM BST) and The US Session (4:00 PM BST).